Clearline Capital LP 13D/13G Filings for TherapeuticsMD, Inc. (TXMD)

Clearline Capital LP 13D and 13G filings for TherapeuticsMD, Inc.:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime		 Transaction
Date		 Type Company
Symbol		 Filed By
Symbol		 Shares Owned
% Owned		 Shares Vs. Prev Report View
2025-02-12
4:25 pm
Sale		 2024-12-31 13G TherapeuticsMD, Inc.
TXMD		 Clearline Capital LP 635,222
5.500%		 -1,400decrease
(-0.22%)		 Filing
2024-11-12
4:40 pm
Purchase		 2024-09-30 13G TherapeuticsMD, Inc.
TXMD		 Clearline Capital LP 636,622
5.520%		 636,622increase
(New Position)		 Filing